|
""Repair Co-ordination of Radiation-Induced Clustered Damage In Mammalian Genome
|
5R01CA158910-04
|
$321,034
|
$321,034
|
MITRA, SANKAR
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
(PQA1)Molecular mechanisms by which the diabetic drug metformin kills cancer cell
|
5R01CA180033-02
|
$286,214
|
$286,214
|
MISKIMINS, W
|
SANFORD RESEARCH/USD
|
|
(PQA2) Impact of obesity on endogenous mutational hotspots
|
1R21CA185508-01
|
$201,623
|
$201,623
|
VASQUEZ, KAREN
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
(PQA2) Interstitial stiffness as a physicochemical modulator of obesity-induced b
|
1R01CA185293-01
|
$345,696
|
$345,696
|
FISCHBACH, CLAUDIA
|
CORNELL UNIVERSITY
|
|
(PQA2) Reversing Carcinogenic Effect of Obesity on Basal-like Breast Cancer
|
5R21CA180134-02
|
$154,570
|
$154,570
|
HAYES, LIZA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
(PQB-3) Characterization of the immune response during mammary tumor initiation
|
1R21CA184541-01
|
$165,300
|
$165,300
|
SCHWERTFEGER, KATHRYN
|
UNIVERSITY OF MINNESOTA
|
|
(PQB3) CD4 T cell response to BCR-ABL-positive Leukemia
|
1R01CA185062-01
|
$310,254
|
$310,254
|
FARRAR, MICHAEL
|
UNIVERSITY OF MINNESOTA
|
|
(PQB3) Investigating innate immunosurveillance of oncogene-induced danger signals
|
1R01CA185020-01
|
$325,183
|
$325,183
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
(PQB5) Does the timing of Pten and Rb1 mutation affect prostate cancer phenotypes
|
5R21CA179907-02
|
$179,119
|
$179,119
|
GOODRICH, DAVID
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
(PQB5) Epigenetic Drivers of Hematopoietic Stem Cell Transformation
|
1R21CA184851-01
|
$230,463
|
$230,463
|
TROWBRIDGE, JENNIFER
|
JACKSON LABORATORY
|
|
(PQB5) Reconstruction of Evolutionary Networks using Cross-Sectional Genomic Data
|
1R01CA185486-01
|
$517,690
|
$517,690
|
RABADAN, RAUL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
(PQB5)Molecular Wiring and Therapeutic Targeting of EGFR and PDGFR Signaling Netw
|
1R01CA185137-01
|
$845,606
|
$845,606
|
CHAREST, ALAIN
|
TUFTS MEDICAL CENTER
|
|
(PQC2) Resistance to fluid shear stress: a novel biomarker of cancer cells
|
5R21CA179981-02
|
$159,287
|
$159,287
|
HENRY, MICHAEL
|
UNIVERSITY OF IOWA
|
|
(PQC2)Nanoscale changes in 3D nuclear architecture during breast tumorigenesis
|
1R01CA185363-01
|
$317,738
|
$317,738
|
LIU, YANG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
(PQC3) Essential Role of BCL9 in Promotion of Human DCIS to Invasive Ductal Carci
|
1R21CA185460-01
|
$197,055
|
$197,055
|
BEHBOD, FARIBA
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
(PQC6) Molecular Determinants of Quiescent Cancer Cells
|
1R01CA185086-01
|
$446,131
|
$446,131
|
RAMASWAMY, SRIDHAR
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
(PQD-1) Selective pressure of antiandrogens on castration resistant prostate canc
|
1R01CA185509-01
|
$258,128
|
$258,128
|
GHOSH, PARAMITA
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
(PQD1) An Iterative Approach for Overcoming Evolving Targeted Therapy Resistance
|
1R01CA185404-01
|
$327,937
|
$327,937
|
WU, LANI
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQD1) Clonal heterogeneity and targeted therapy resistance in melanoma
|
1R01CA185072-01
|
$382,030
|
$382,030
|
SEKULIC, ALEKSANDAR
|
MAYO CLINIC ARIZONA
|
|
(PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers
|
5R01CA180037-02
|
$318,099
|
$318,099
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition
|
5R01CA180150-02
|
$541,578
|
$541,578
|
PETROSKI, MATTHEW
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
(PQD2) Molecular Basis for the Chemosensitivity of Testicular Germ Cell Cancers
|
1R21CA185256-01
|
$168,563
|
$168,563
|
WEISS, ROBERT
|
CORNELL UNIVERSITY
|
|
(PQD3) Mechanisms of prolonged initial disease-free survival in glioblastoma
|
1R01CA184320-01
|
$669,147
|
$669,147
|
SARKARIA, JANN
|
MAYO CLINIC ROCHESTER
|
|
(PQD4) Epigenetic loss of heterozygosity as a driver of the cancer field effect
|
1R21CA185000-01
|
$221,954
|
$221,954
|
GIMELBRANT, ALEXANDER
|
DANA-FARBER CANCER INST
|
|
(PQD4) MicroRNA Dysregulation in Field Effect is a Prerequisite for Tumorigenesis
|
1R21CA185504-01
|
$194,119
|
$194,119
|
YANG, ZENG-JIE
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
(PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies
|
1R01CA185372-01
|
$329,519
|
$329,519
|
RICHARDS, KRISTY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
00005I-5572 NCI-DCCPS -- 8481398
|
271201000005I
|
$738,654
|
$738,654
|
UNKNOWN, UNKNOWN
|
KELLY SERVICES INC
|
|
13th International Workshop on Radiation Damage to DNA
|
1R13CA186669-01
|
$6,500
|
$6,500
|
DEDON, PETER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
20 GRAMS OF CAS, REGISTRY # 1015447-26-3. MA32504
|
261201400494P
|
$23,000
|
$23,000
|
UNKNOWN, UNKNOWN
|
UNKNOWN
|
|
2010 Cold Spring Harbor Laboratory Conference on Systems Biology: Global Regulati
|
5R13CA150295-03
|
$5,000
|
$5,000
|
STEWART, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
2014 Annual Meeting of the American Society for Investigative Pathology
|
1R13CA186413-01
|
$2,500
|
$2,500
|
LUSCINSKAS, FRANCIS
|
AMERICAN SOCIETY/INVESTIGATIVE PATHOLOGY
|
|
2014 ASPO conference grant
|
1R13CA186680-01
|
$30,000
|
$30,000
|
TRENTHAM-DIETZ, AMY
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
2014 AUA Urological Oncology Research Symposium: ""Progress in Translational Uro
|
1R13CA186649-01
|
$6,000
|
$6,000
|
GIAMBARRESI, LEO
|
AMERICAN UROLOGICAL ASSOCIATION
|
|
2014 Cell Death Gordon Research Conference
|
1R13CA186195-01
|
$5,000
|
$5,000
|
BAEHRECKE, ERIC
|
GORDON RESEARCH CONFERENCES
|
|
2014 Fibroblast Growth Factors in Development & Disease Gordon Research Conferenc
|
1R13HD079129-01
|
$2,000
|
$2,000
|
WANG, FEN
|
GORDON RESEARCH CONFERENCES
|
|
2014 International Research Congress on Integrative Medicine and Health
|
1R13AT008325-01
|
$3,000
|
$3,000
|
HARAMATI, AVIAD
|
GEORGETOWN UNIVERSITY
|
|
2014 Lasers in Medicine and Biology Gordon Research Conference
|
1R13EB018631-01
|
$5,000
|
$5,000
|
BOPPART, STEPHEN
|
GORDON RESEARCH CONFERENCES
|
|
2014 Metals in Medicine Gordon Research Conference
|
1R13EB018639-01
|
$5,000
|
$5,000
|
PACKARD, ALAN
|
GORDON RESEARCH CONFERENCES
|
|
2014 Notch Signaling in Development & Disease Gordon Research Conference/Seminar
|
1R13HD080297-01
|
$3,000
|
$3,000
|
Blacklow, Stephen
|
GORDON RESEARCH CONFERENCES
|
|
2014 Radiation Chemistry Gordon Research Conferences and Gordon Research Seminar
|
1R13CA189237-01
|
$5,000
|
$5,000
|
LAVERNE, JAY
|
GORDON RESEARCH CONFERENCES
|
|
2014 Signaling by Adhesion Receptors Gordon Research Conference & Gordon Research
|
1R13CA186308-01
|
$6,000
|
$6,000
|
HUMPHRIES, MARTIN
|
GORDON RESEARCH CONFERENCES
|
|
3D-Microtumor_GBM Xenoline Proband Modeling of Kinome-Directed Therapy
|
1R21CA185712-01
|
$203,585
|
$203,585
|
WILLEY, CHRISTOPHER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
402 - NORTH AMERICAN ASSOCIATION OF CENTRAL CANCER REGISTRIES, INC. (NAACCR); TE
|
261201400004I
|
$688,174
|
$688,174
|
UNKNOWN, UNKNOWN
|
NORTH AMERICAN ASSOCIATION OF CENTRAL CA
|
|
402 - TECHNICAL AND LOGISTICAL SUPPORT FOR CANCER SURVEILLANCE; CORNERSTONE SYST
|
261201300002I
|
$217,172
|
$217,172
|
UNKNOWN, UNKNOWN
|
CORNERSTONE SYSTEMS NORTHWEST INCORPORAT
|
|
402 - TITLE: CANCER PREVENTION CLINICAL TRIALS AUDITING INFORMATICS SUPPORT. C
|
261201490002I
|
$2,058,158
|
$2,058,158
|
UNKNOWN, UNKNOWN
|
TECHNICAL RESOURCES INC
|
|
402 -- TITLE: MODIFICATION TO EXERCISE OPTION PERIOD 5. CONTRACTOR: WESTAT INTERN
|
N1CN25476A
|
$1,728,293
|
$1,728,293
|
UNKNOWN, UNKNOWN
|
WESTAT, INC.
|
|
402 -- TITLE: PHASE II, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PROSTVAC (PSA-TR
|
261201200031I
|
$3,052,930
|
$3,052,930
|
UNKNOWN, UNKNOWN
|
UNIVERSITY OF ARIZONA
|
|
???Novel melampomagnolide B-based prodrugs for the treatment of leukemia???
|
5R01CA158275-05
|
$303,926
|
$303,926
|
CROOKS, PETER
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
A bifunctional nanomedicine for both specific imaging and targeting therapy of an
|
5R01CA151955-05
|
$300,665
|
$300,665
|
ZU, YOULI
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
A biophysical stromal basis for radiation sensitivity in ductal carcinoma in situ
|
1R01CA174929-01A1
|
$678,168
|
$678,168
|
PARK, CATHERINE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
Total relevant funding to Cancer for this search: $1,650,488,361
|